https://www.selleckchem.com/products/ml323.html
While combined antiretroviral therapy (cART) allows near-normal life expectancy for people living with human immunodeficiency virus (HIV), it is unable to cure the infection and so life long treatment is required. The main barrier to curing HIV is the latent reservoir of cells, which is stable and resistant to cART. Current approaches under investigation for clearing this reservoir propose a 'Shock and Kill' mechanism, in which active replication is induced in latent cells by latency reversal agents, theoretically allowing killing of the
Like
Comment
Share
